Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 2-3/2015

01-06-2015

Women and Primary Biliary Cirrhosis

Authors: Ying Sun, Krista Haapanen, Baosen Li, Weici Zhang, Judy Van de Water, M. Eric Gershwin

Published in: Clinical Reviews in Allergy & Immunology | Issue 2-3/2015

Login to get access

Abstract

Primary biliary cirrhosis occurs more frequently in women, and previous studies indicated that the average age of primary biliary cirrhosis (PBC) onset makes pregnancy in PBC patients uncommon. However, more recently, improved diagnostic testing has enabled detection of PBC in younger women, including those of childbearing age. This has led investigators to become increasingly interested in the relationship between the ontogeny of PBC and pregnancy. Published cases indicate that the typical age for pregnant women to be diagnosed with PBC is in the early 30s, and that during gestation, pruritus and jaundice are the most common symptoms. During gestation, susceptible women may experience onset of PBC resulting from the drastic changes in female hormones; this would include not only the mitochondrial damage due to accumulation of bile acids but also changes in the immune response during the different stages of pregnancy that might play an important role in the breakdown of self-tolerance. The mechanisms underlying the potential relationship between PBC and pregnancy warrant further investigation. For women first diagnosed with PBC during gestation, or those for whom first appearance of a flare up occurs during and postpartum, investigation of the immune response throughout gestation could provide new avenues for immunologic therapeutic intervention and the discovery of new treatment strategies for PBC.
Literature
1.
go back to reference Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273PubMed Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273PubMed
2.
go back to reference Trivedi PJ, Kumagi T, Al-Harthy N, Coltescu C, Ward S, Cheung A et al (2014) Good maternal and fetal outcomes for pregnant women with primary biliary cirrhosis. Clin gastroenterol and hepatol: the off clin practice j of the Am Gastroenterol Assoc 12:1179–1185 Trivedi PJ, Kumagi T, Al-Harthy N, Coltescu C, Ward S, Cheung A et al (2014) Good maternal and fetal outcomes for pregnant women with primary biliary cirrhosis. Clin gastroenterol and hepatol: the off clin practice j of the Am Gastroenterol Assoc 12:1179–1185
3.
go back to reference Prince MI, James OF (2003) The epidemiology of primary biliary cirrhosis. Clin in Liver Dis 7:795–819 Prince MI, James OF (2003) The epidemiology of primary biliary cirrhosis. Clin in Liver Dis 7:795–819
4.
go back to reference Floreani A, Infantolino C, Franceschet I, Tene IM, Cazzagon N, Buja A et al. (2014) Pregnancy and primary biliary cirrhosis: a case–control study. Clinical reviews in allergy & immunology Floreani A, Infantolino C, Franceschet I, Tene IM, Cazzagon N, Buja A et al. (2014) Pregnancy and primary biliary cirrhosis: a case–control study. Clinical reviews in allergy & immunology
5.
go back to reference Efe C, Kahramanoglu-Aksoy E, Yilmaz B, Ozseker B, Takci S, Roach EC et al. (2014) pregnancy in primary biliary cirrhosis. Autoimmunity reviews Efe C, Kahramanoglu-Aksoy E, Yilmaz B, Ozseker B, Takci S, Roach EC et al. (2014) pregnancy in primary biliary cirrhosis. Autoimmunity reviews
6.
go back to reference Parikh-Patel A, Gold E, Utts J, Gershwin ME (2002) The association between gravidity and primary biliary cirrhosis. Ann Epidemiol 12:264–272PubMedPubMedCentral Parikh-Patel A, Gold E, Utts J, Gershwin ME (2002) The association between gravidity and primary biliary cirrhosis. Ann Epidemiol 12:264–272PubMedPubMedCentral
7.
go back to reference Miller FW, Pollard KM, Parks CG, Germolec DR, Leung PS, Selmi C et al (2012) Criteria for environmentally associated autoimmune diseases. J Autoimmun 39:253–258PubMedPubMedCentral Miller FW, Pollard KM, Parks CG, Germolec DR, Leung PS, Selmi C et al (2012) Criteria for environmentally associated autoimmune diseases. J Autoimmun 39:253–258PubMedPubMedCentral
8.
go back to reference Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M et al (2012) Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39:272–284PubMed Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M et al (2012) Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39:272–284PubMed
9.
go back to reference Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259–271PubMedPubMedCentral Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 39:259–271PubMedPubMedCentral
10.
go back to reference Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM (2012) Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 38:J109–J119PubMed Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM (2012) Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 38:J109–J119PubMed
11.
go back to reference Menon R, Di Dario M, Cordiglieri C, Musio S, La Mantia L, Milanese C et al (2012) Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 38:J144–J155PubMed Menon R, Di Dario M, Cordiglieri C, Musio S, La Mantia L, Milanese C et al (2012) Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 38:J144–J155PubMed
12.
go back to reference Pollard KM (2012) Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 38:J177–J186PubMedPubMedCentral Pollard KM (2012) Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun 38:J177–J186PubMedPubMedCentral
13.
go back to reference Pennell LM, Galligan CL, Fish EN (2012) Sex affects immunity. J Autoimmun 38:J282–J291PubMed Pennell LM, Galligan CL, Fish EN (2012) Sex affects immunity. J Autoimmun 38:J282–J291PubMed
14.
go back to reference Shoenfeld Y, Tincani A, Gershwin ME (2012) Sex gender and autoimmunity. J Autoimmun 38:J71–J73PubMed Shoenfeld Y, Tincani A, Gershwin ME (2012) Sex gender and autoimmunity. J Autoimmun 38:J71–J73PubMed
15.
go back to reference Amur S, Parekh A, Mummaneni P (2012) Sex differences and genomics in autoimmune diseases. J Autoimmun 38:J254–J265PubMed Amur S, Parekh A, Mummaneni P (2012) Sex differences and genomics in autoimmune diseases. J Autoimmun 38:J254–J265PubMed
16.
go back to reference Ostensen M (1992) The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am j of reprod immunol: AJRI 28:235–237PubMed Ostensen M (1992) The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am j of reprod immunol: AJRI 28:235–237PubMed
17.
go back to reference Kaaja RJ, Greer IA (2005) Manifestations of chronic disease during pregnancy. JAMA: the j of the Am Med Assoc 294:2751–2757 Kaaja RJ, Greer IA (2005) Manifestations of chronic disease during pregnancy. JAMA: the j of the Am Med Assoc 294:2751–2757
18.
go back to reference Ostensen M, Villiger PM, Forger F (2012) Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 11:A437–A446PubMed Ostensen M, Villiger PM, Forger F (2012) Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 11:A437–A446PubMed
19.
go back to reference De Carolis S, Salvi S, Botta A, Garofalo S, Garufi C, Ferrazzani S et al (2014) The impact of primary Sjogren’s syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev 13:103–107PubMed De Carolis S, Salvi S, Botta A, Garofalo S, Garufi C, Ferrazzani S et al (2014) The impact of primary Sjogren’s syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev 13:103–107PubMed
20.
go back to reference Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R et al (2012) Pregnancy and vasculitis: a systematic review of the literature. Autoimmun Rev 11:A447–A459PubMed Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R et al (2012) Pregnancy and vasculitis: a systematic review of the literature. Autoimmun Rev 11:A447–A459PubMed
21.
go back to reference Westbrook RH, Yeoman AD, Kriese S, Heneghan MA (2012) Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 38:J239–J244PubMed Westbrook RH, Yeoman AD, Kriese S, Heneghan MA (2012) Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 38:J239–J244PubMed
22.
go back to reference Falany CN, Johnson MR, Barnes S, Diasio RB (1994) Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. The J of Biol Chem 269:19375–19379 Falany CN, Johnson MR, Barnes S, Diasio RB (1994) Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. The J of Biol Chem 269:19375–19379
23.
go back to reference White BA, Fricke RJ, Hylemon PB (1982) 7 beta-Dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708. J Lipid Res 23:145–153PubMed White BA, Fricke RJ, Hylemon PB (1982) 7 beta-Dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708. J Lipid Res 23:145–153PubMed
24.
go back to reference Houten SM, Watanabe M, Auwerx J (2006) Endocrine functions of bile acids. The EMBO J 25:1419–1425 Houten SM, Watanabe M, Auwerx J (2006) Endocrine functions of bile acids. The EMBO J 25:1419–1425
25.
go back to reference Yousef IM, Magnusson R, Price VM, Fisher MM (1973) Bile acid metabolism in mammals. V. Studies on the sex difference in the response of the isolated perfused rat liver to chenodeoxycholic acid. Can J Physiol Pharmacol 51:418–423PubMed Yousef IM, Magnusson R, Price VM, Fisher MM (1973) Bile acid metabolism in mammals. V. Studies on the sex difference in the response of the isolated perfused rat liver to chenodeoxycholic acid. Can J Physiol Pharmacol 51:418–423PubMed
26.
go back to reference Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M et al (2003) Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. The J of Biol Chem 278:17838–17844 Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M et al (2003) Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. The J of Biol Chem 278:17838–17844
27.
go back to reference Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, Sutherland E (1996) Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. The Am J of Physiol 271:G1043–G1052 Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, Sutherland E (1996) Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. The Am J of Physiol 271:G1043–G1052
28.
go back to reference Geier A, Wagner M, Dietrich CG, Trauner M (2007) Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 1773:283–308PubMed Geier A, Wagner M, Dietrich CG, Trauner M (2007) Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 1773:283–308PubMed
30.
go back to reference Davis RA, Kern F Jr, Showalter R, Sutherland E, Sinensky M, Simon FR (1978) Alterations of hepatic Na+, K+−atpase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci U S A 75:4130–4134PubMedPubMedCentral Davis RA, Kern F Jr, Showalter R, Sutherland E, Sinensky M, Simon FR (1978) Alterations of hepatic Na+, K+−atpase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci U S A 75:4130–4134PubMedPubMedCentral
31.
go back to reference Elias E, Iqbal S, Knutton S, Hickey A, Coleman R (1983) Increased tight junction permeability: a possible mechanism of oestrogen cholestasis. Eur J Clin Investig 13:383–390 Elias E, Iqbal S, Knutton S, Hickey A, Coleman R (1983) Increased tight junction permeability: a possible mechanism of oestrogen cholestasis. Eur J Clin Investig 13:383–390
32.
go back to reference Jung D, Podvinec M, Meyer UA, Mangelsdorf DJ, Fried M, Meier PJ et al (2002) Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 122:1954–1966PubMed Jung D, Podvinec M, Meyer UA, Mangelsdorf DJ, Fried M, Meier PJ et al (2002) Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology 122:1954–1966PubMed
33.
go back to reference Aleksunes LM, Yeager RL, Wen X, Cui JY, Klaassen CD (2012) Repression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy. Toxicol Sci.130:257–268PubMedPubMedCentral Aleksunes LM, Yeager RL, Wen X, Cui JY, Klaassen CD (2012) Repression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy. Toxicol Sci.130:257–268PubMedPubMedCentral
34.
go back to reference Jeong S, Yoon M (2007) Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen. Obesity 15:1430–1440PubMed Jeong S, Yoon M (2007) Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen. Obesity 15:1430–1440PubMed
35.
go back to reference Milona A, Owen BM, Cobbold JF, Willemsen EC, Cox IJ, Boudjelal M et al (2010) Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 52:1341–1349PubMed Milona A, Owen BM, Cobbold JF, Willemsen EC, Cox IJ, Boudjelal M et al (2010) Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology 52:1341–1349PubMed
36.
go back to reference Huang L, Smit JW, Meijer DK, Vore M (2000) Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats. Hepatology 32:66–72PubMed Huang L, Smit JW, Meijer DK, Vore M (2000) Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats. Hepatology 32:66–72PubMed
37.
go back to reference Spivey JR, Bronk SF, Gores GJ (1993) Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest 92:17–24PubMedPubMedCentral Spivey JR, Bronk SF, Gores GJ (1993) Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest 92:17–24PubMedPubMedCentral
38.
go back to reference Poupon RE, Balkau B, Eschwege E, Poupon R (1991) A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 324:1548–1554PubMed Poupon RE, Balkau B, Eschwege E, Poupon R (1991) A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 324:1548–1554PubMed
39.
go back to reference Lamireau T, Zoltowska M, Levy E, Yousef I, Rosenbaum J, Tuchweber B et al (2003) Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci 72:1401–1411PubMed Lamireau T, Zoltowska M, Levy E, Yousef I, Rosenbaum J, Tuchweber B et al (2003) Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci 72:1401–1411PubMed
40.
go back to reference Alpini G, Glaser SS, Ueno Y, Rodgers R, Phinizy JL, Francis H et al (1999) Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 116:179–186PubMed Alpini G, Glaser SS, Ueno Y, Rodgers R, Phinizy JL, Francis H et al (1999) Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 116:179–186PubMed
41.
go back to reference Alpini G, Ueno Y, Glaser SS, Marzioni M, Phinizy JL, Francis H et al (2001) Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 34:868–876PubMed Alpini G, Ueno Y, Glaser SS, Marzioni M, Phinizy JL, Francis H et al (2001) Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 34:868–876PubMed
42.
go back to reference Lazaridis KN, Pham L, Tietz P, Marinelli RA, DeGroen PC, Levine S et al (1997) Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest 100:2714–2721PubMedPubMedCentral Lazaridis KN, Pham L, Tietz P, Marinelli RA, DeGroen PC, Levine S et al (1997) Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest 100:2714–2721PubMedPubMedCentral
43.
go back to reference Alpini G, Baiocchi L, Glaser S, Ueno Y, Marzioni M, Francis H et al (2002) Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology 35:1041–1052PubMed Alpini G, Baiocchi L, Glaser S, Ueno Y, Marzioni M, Francis H et al (2002) Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology  35:1041–1052PubMed
44.
go back to reference Alpini G, Glaser S, Robertson W, Phinizy JL, Rodgers RE, Caligiuri A et al (1997) Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. The Am J of Physiol 273:G518–G529 Alpini G, Glaser S, Robertson W, Phinizy JL, Rodgers RE, Caligiuri A et al (1997) Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. The Am J of Physiol 273:G518–G529
45.
go back to reference Paumgartner G, Beuers U (2002) Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36:525–531PubMed Paumgartner G, Beuers U (2002) Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36:525–531PubMed
46.
go back to reference Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313–326PubMedPubMedCentral Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313–326PubMedPubMedCentral
47.
go back to reference Demetris AJ, Lunz JG 3rd, Specht S, Nozaki I (2006) Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol 12:3512–3522PubMedPubMedCentral Demetris AJ, Lunz JG 3rd, Specht S, Nozaki I (2006) Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol 12:3512–3522PubMedPubMedCentral
48.
go back to reference Benedetti A, Alvaro D, Bassotti C, Gigliozzi A, Ferretti G, La Rosa T et al (1997) Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology 26:9–21PubMed Benedetti A, Alvaro D, Bassotti C, Gigliozzi A, Ferretti G, La Rosa T et al (1997) Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology 26:9–21PubMed
49.
go back to reference Heuman DM, Pandak WM, Hylemon PB, Vlahcevic ZR (1991) Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 14:920–926PubMed Heuman DM, Pandak WM, Hylemon PB, Vlahcevic ZR (1991) Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 14:920–926PubMed
50.
go back to reference Miyazaki K, Nakayama F, Koga A (1984) Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes. Dig Dis Sci 29:1123–1130PubMed Miyazaki K, Nakayama F, Koga A (1984) Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes. Dig Dis Sci 29:1123–1130PubMed
51.
go back to reference Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, and Shafritz DA et al (1994) Bile acids. The liver: biology and pathobiology, third edition. New York: Raven 677–718 Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, and Shafritz DA et al (1994) Bile acids. The liver: biology and pathobiology, third edition. New York: Raven 677–718
52.
go back to reference Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMed Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMed
53.
go back to reference Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev 28:521–574PubMed Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev 28:521–574PubMed
54.
go back to reference Pillai S (2013) Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun 45:97–103PubMed Pillai S (2013) Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun 45:97–103PubMed
55.
go back to reference Neuberger JM (1997) Primary biliary cirrhosis. Lancet 350:875-879 Neuberger JM (1997) Primary biliary cirrhosis. Lancet 350:875-879
56.
go back to reference Ahlqvist J (1980) Can endocrine factors influence pathogenetic mechanisms in chronic active hepatitis (CAH) and primary biliary cirrhosis (PBC)? A hypothesis. Hepatogastroenterology 27:64–67PubMed Ahlqvist J (1980) Can endocrine factors influence pathogenetic mechanisms in chronic active hepatitis (CAH) and primary biliary cirrhosis (PBC)? A hypothesis. Hepatogastroenterology 27:64–67PubMed
57.
go back to reference Floreani A, Titta M, Plebani M, Faggian D, Chiaramonte M, Naccarato R (1991) Sex hormone changes in post-menopausal women with primary biliary cirrhosis (PBC) and with cryptogenic chronic liver disease. Clin and Exp Obstet & Gynecol 18:229–234 Floreani A, Titta M, Plebani M, Faggian D, Chiaramonte M, Naccarato R (1991) Sex hormone changes in post-menopausal women with primary biliary cirrhosis (PBC) and with cryptogenic chronic liver disease. Clin and Exp Obstet & Gynecol 18:229–234
58.
go back to reference Desmet VJ, van Eyken P, Roskams T (1998) Histopathology of vanishing bile duct diseases. Adv Clin Path 2:87–99PubMed Desmet VJ, van Eyken P, Roskams T (1998) Histopathology of vanishing bile duct diseases. Adv Clin Path 2:87–99PubMed
59.
go back to reference Desmet V, Roskams T, Van Eyken P (1995) Ductular reaction in the liver. Pathol Res Pract 191:513–524PubMed Desmet V, Roskams T, Van Eyken P (1995) Ductular reaction in the liver. Pathol Res Pract 191:513–524PubMed
60.
go back to reference Sampson LK, Vickers SM, Ying W, Phillips JO (1997) Tamoxifen-mediated growth inhibition of human cholangiocarcinoma. Cancer Res 57:1743–1749PubMed Sampson LK, Vickers SM, Ying W, Phillips JO (1997) Tamoxifen-mediated growth inhibition of human cholangiocarcinoma. Cancer Res 57:1743–1749PubMed
61.
go back to reference Floreani A, Paternoster D, Mega A, Farinati F, Plebani M, Baldo V et al (2002) Sex hormone profile and endometrial cancer risk in primary biliary cirrhosis: a case–control study. Eur J Obstet Gynecol Reprod Biol 103:154–157PubMed Floreani A, Paternoster D, Mega A, Farinati F, Plebani M, Baldo V et al (2002) Sex hormone profile and endometrial cancer risk in primary biliary cirrhosis: a case–control study. Eur J Obstet Gynecol Reprod Biol 103:154–157PubMed
62.
go back to reference Stellon AJ, Williams R (1986) Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J (Clin Res Ed) 293:297–298 Stellon AJ, Williams R (1986) Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J (Clin Res Ed) 293:297–298
63.
go back to reference Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103:855–860PubMed Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL (1985) Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 103:855–860PubMed
64.
go back to reference Olsson R, Mattsson LA, Obrant K, Mellstrom D (1999) Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 19:188–192PubMed Olsson R, Mattsson LA, Obrant K, Mellstrom D (1999) Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 19:188–192PubMed
65.
go back to reference Chen J, Robertson G, Field J, Liddle C, Farrell GC (1998) Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats. Hepatology 28:624–630PubMed Chen J, Robertson G, Field J, Liddle C, Farrell GC (1998) Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats. Hepatology 28:624–630PubMed
66.
go back to reference Eagon PK, Porter LE, Francavilla A, DiLeo A, Van Thiel DH (1985) Estrogen and androgen receptors in liver: their role in liver disease and regeneration. Semin Liver Dis 5:59–69PubMed Eagon PK, Porter LE, Francavilla A, DiLeo A, Van Thiel DH (1985) Estrogen and androgen receptors in liver: their role in liver disease and regeneration. Semin Liver Dis 5:59–69PubMed
67.
go back to reference Blum A, Cannon RO 3rd (1998) Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function. Curr Opin Lipidol 9:575–586PubMed Blum A, Cannon RO 3rd (1998) Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function. Curr Opin Lipidol 9:575–586PubMed
68.
go back to reference Eagon PK, Elm MS, Epley MJ, Shinozuka H, Rao KN (1996) Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. Gastroenterology 110:1199–1207PubMed Eagon PK, Elm MS, Epley MJ, Shinozuka H, Rao KN (1996) Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. Gastroenterology 110:1199–1207PubMed
69.
go back to reference Fisher B, Gunduz N, Saffer EA, Zheng S (1984) Relation of estrogen and its receptor to rat liver growth and regeneration. Cancer Res 44:2410–2415PubMed Fisher B, Gunduz N, Saffer EA, Zheng S (1984) Relation of estrogen and its receptor to rat liver growth and regeneration. Cancer Res 44:2410–2415PubMed
70.
go back to reference Alvaro D, Alpini G, Onori P, Perego L, Svegliata Baroni G, Franchitto A et al (2000) Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 119:1681–1691PubMed Alvaro D, Alpini G, Onori P, Perego L, Svegliata Baroni G, Franchitto A et al (2000) Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 119:1681–1691PubMed
71.
go back to reference Alvaro D, Alpini G, Onori P, Franchitto A, Glaser SS, Le Sage G et al (2002) Alfa and beta estrogen receptors and the biliary tree. Mol Cell Endocrinol 193:105–108PubMed Alvaro D, Alpini G, Onori P, Franchitto A, Glaser SS, Le Sage G et al (2002) Alfa and beta estrogen receptors and the biliary tree. Mol Cell Endocrinol 193:105–108PubMed
72.
go back to reference Alvaro D, Alpini G, Onori P, Franchitto A, Glaser S, Le Sage G et al (2002) Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 123:336–344PubMed Alvaro D, Alpini G, Onori P, Franchitto A, Glaser S, Le Sage G et al (2002) Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 123:336–344PubMed
73.
go back to reference Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A et al (2004) Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 41:905–912PubMed Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A et al (2004) Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 41:905–912PubMed
74.
go back to reference Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Delunardo F, Vacirca D et al (2010) Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 132:79–85PubMed Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Delunardo F, Vacirca D et al (2010) Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 132:79–85PubMed
75.
go back to reference Phiel KL, Henderson RA, Adelman SJ, Elloso MM (2005) Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 97:107–113PubMed Phiel KL, Henderson RA, Adelman SJ, Elloso MM (2005) Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 97:107–113PubMed
76.
go back to reference Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ et al (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508–1510PubMed Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ et al (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508–1510PubMed
77.
go back to reference Gigliozzi A, Alpini G, Baroni GS, Marucci L, Metalli VD, Glaser SS et al (2004) Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 127:1198–1209PubMed Gigliozzi A, Alpini G, Baroni GS, Marucci L, Metalli VD, Glaser SS et al (2004) Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 127:1198–1209PubMed
78.
go back to reference Alvaro D, Metalli VD, Alpini G, Onori P, Franchitto A, Barbaro B et al (2005) The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol 43:875–883PubMed Alvaro D, Metalli VD, Alpini G, Onori P, Franchitto A, Barbaro B et al (2005) The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. J Hepatol 43:875–883PubMed
79.
go back to reference Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Ueno Y et al (2006) Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 130:1270–1282PubMed Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Ueno Y et al (2006) Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 130:1270–1282PubMed
80.
go back to reference You Z, Wang Q, Bian Z, Liu Y, Han X, Peng Y et al (2012) The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun 39:216–221PubMedPubMedCentral You Z, Wang Q, Bian Z, Liu Y, Han X, Peng Y et al (2012) The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun 39:216–221PubMedPubMedCentral
81.
go back to reference Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42:1194–1202PubMedPubMedCentral Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42:1194–1202PubMedPubMedCentral
82.
go back to reference Corpechot C, Chretien Y, Chazouilleres O, Poupon R (2010) Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53:162–169PubMed Corpechot C, Chretien Y, Chazouilleres O, Poupon R (2010) Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53:162–169PubMed
83.
go back to reference Compagnone NA, Mellon SH (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21:1–56PubMed Compagnone NA, Mellon SH (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21:1–56PubMed
84.
go back to reference Micevych PE, Chaban V, Ogi J, Dewing P, Lu JK, Sinchak K (2007) Estradiol stimulates progesterone synthesis in hypothalamic astrocyte cultures. Endocrinology 148:782–789PubMed Micevych PE, Chaban V, Ogi J, Dewing P, Lu JK, Sinchak K (2007) Estradiol stimulates progesterone synthesis in hypothalamic astrocyte cultures. Endocrinology 148:782–789PubMed
85.
go back to reference Glaser S, DeMorrow S, Francis H, Ueno Y, Gaudio E, Vaculin S et al (2008) Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol 295:G124–G136PubMedPubMedCentral Glaser S, DeMorrow S, Francis H, Ueno Y, Gaudio E, Vaculin S et al (2008) Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol 295:G124–G136PubMedPubMedCentral
86.
go back to reference Taffetani S, Glaser S, Francis H, DeMorrow S, Ueno Y, Alvaro D et al (2007) Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms. BMC Physiol 7:6PubMedPubMedCentral Taffetani S, Glaser S, Francis H, DeMorrow S, Ueno Y, Alvaro D et al (2007) Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms. BMC Physiol 7:6PubMedPubMedCentral
87.
go back to reference Roskams T, Desmet V (1998) Ductular reaction and its diagnostic significance. Semin Diagn Pathol 15:259–269PubMed Roskams T, Desmet V (1998) Ductular reaction and its diagnostic significance. Semin Diagn Pathol 15:259–269PubMed
88.
go back to reference Alvaro D, Onori P, Metalli VD, Svegliati-Baroni G, Folli F, Franchitto A et al (2002) Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 36:297–304PubMed Alvaro D, Onori P, Metalli VD, Svegliati-Baroni G, Folli F, Franchitto A et al (2002) Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 36:297–304PubMed
89.
go back to reference Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA (2004) Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 15:390–397PubMed Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA (2004) Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 15:390–397PubMed
90.
go back to reference Burns WC, Kantharidis P, Thomas MC (2007) The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 185:222–231PubMed Burns WC, Kantharidis P, Thomas MC (2007) The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 185:222–231PubMed
91.
go back to reference Diaz R, Kim JW, Hui JJ, Li Z, Swain GP, Fong KS et al (2008) Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 39:102–115PubMed Diaz R, Kim JW, Hui JJ, Li Z, Swain GP, Fong KS et al (2008) Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 39:102–115PubMed
92.
go back to reference Omenetti A, Yang L, Li YX, McCall SJ, Jung Y, Sicklick JK et al (2007) Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest 87:499–514PubMed Omenetti A, Yang L, Li YX, McCall SJ, Jung Y, Sicklick JK et al (2007) Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest 87:499–514PubMed
93.
go back to reference Ahrens EH Jr, Payne MA, Kunkel HG, Eisenmenger WJ, Blondheim SH (1950) Primary biliary cirrhosis. Medicine 29:299–364PubMed Ahrens EH Jr, Payne MA, Kunkel HG, Eisenmenger WJ, Blondheim SH (1950) Primary biliary cirrhosis. Medicine 29:299–364PubMed
94.
go back to reference Olsson R, Loof L, Wallerstedt S (1993) Pregnancy in patients with primary biliary cirrhosis—a case for dissuasion? The Swedish Internal Medicine Liver Club. Liver 13:316–318PubMed Olsson R, Loof L, Wallerstedt S (1993) Pregnancy in patients with primary biliary cirrhosis—a case for dissuasion? The Swedish Internal Medicine Liver Club. Liver 13:316–318PubMed
95.
go back to reference Whelton MJ, Sherlock S (1968) Pregnancy in patients with hepatic cirrhosis. Manag and outcome Lancet 2:995–999 Whelton MJ, Sherlock S (1968) Pregnancy in patients with hepatic cirrhosis. Manag and outcome Lancet 2:995–999
96.
go back to reference Nir A, Sorokin Y, Abramovici H, Theodor E (1989) Pregnancy and primary biliary cirrhosis. Int J Gynaecol Obstet 28:279–282PubMed Nir A, Sorokin Y, Abramovici H, Theodor E (1989) Pregnancy and primary biliary cirrhosis. Int J Gynaecol Obstet 28:279–282PubMed
97.
go back to reference Rabinovitz M, Appasamy R, Finkelstein S (1995) Primary biliary cirrhosis diagnosed during pregnancy. Does it have a different outcome? Dig Dis Sci 40:571–574PubMed Rabinovitz M, Appasamy R, Finkelstein S (1995) Primary biliary cirrhosis diagnosed during pregnancy. Does it have a different outcome? Dig Dis Sci 40:571–574PubMed
98.
go back to reference Mack HC, Segar LF, Robinson AR, Wiseman ME, Moyer EZ (1953) Electrophoretic patterns of plasma proteins in pregnancy II. Pregnancy complicated by liver disease. Obstet Gynecol 1:204–211PubMed Mack HC, Segar LF, Robinson AR, Wiseman ME, Moyer EZ (1953) Electrophoretic patterns of plasma proteins in pregnancy II. Pregnancy complicated by liver disease. Obstet Gynecol 1:204–211PubMed
99.
go back to reference Wong Kk GKL (1992) Pregnancy in primary biliary cirrhosis. Eur J Obstet Gynecol Reprod Biol 45:149–151PubMed Wong Kk GKL (1992) Pregnancy in primary biliary cirrhosis. Eur J Obstet Gynecol Reprod Biol 45:149–151PubMed
100.
go back to reference Ji H, Haring P, Kirkinen P, Saarikoski S (1995) Glucocorticoid treatment of primary biliary cirrhosis in a pregnant woman. Acta Obstet Gynecol Scand 74:654–656PubMed Ji H, Haring P, Kirkinen P, Saarikoski S (1995) Glucocorticoid treatment of primary biliary cirrhosis in a pregnant woman. Acta Obstet Gynecol Scand 74:654–656PubMed
101.
go back to reference Rudi J, Schonig T, Stremmel W (1996) Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Z Gastroenterol 34:188–191PubMed Rudi J, Schonig T, Stremmel W (1996) Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Z Gastroenterol 34:188–191PubMed
102.
go back to reference Goh SK, Gull SE, Alexander GJ (2001) Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature. BJOG 108:760–762PubMed Goh SK, Gull SE, Alexander GJ (2001) Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature. BJOG 108:760–762PubMed
103.
go back to reference Korkut E, Kisacik B, Akcan Y, Belenli O, Bicik Z, Yucel O (2005) Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis. Fertil Steril 83:761–763PubMed Korkut E, Kisacik B, Akcan Y, Belenli O, Bicik Z, Yucel O (2005) Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis. Fertil Steril 83:761–763PubMed
104.
go back to reference Poupon R, Chretien Y, Chazouilleres O, Poupon RE (2005) Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol 42:418–419PubMed Poupon R, Chretien Y, Chazouilleres O, Poupon RE (2005) Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol 42:418–419PubMed
105.
go back to reference Ohba K, Omagari K, Kusakari C, Kadokawa Y, Hayashida K, Takeshima F et al (2005) Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis. Dig Dis Sci 50:201–206PubMed Ohba K, Omagari K, Kusakari C, Kadokawa Y, Hayashida K, Takeshima F et al (2005) Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis. Dig Dis Sci 50:201–206PubMed
106.
go back to reference Alallam A, Barth D, Heathcote EJ (2008) Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can J Gastroenterol 22:505–507PubMedPubMedCentral Alallam A, Barth D, Heathcote EJ (2008) Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can J Gastroenterol 22:505–507PubMedPubMedCentral
107.
go back to reference Vitek L, Zelenkova M, Bruha R (2010) Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Dig Liver Dis 42:911–912PubMed Vitek L, Zelenkova M, Bruha R (2010) Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Dig Liver Dis 42:911–912PubMed
108.
go back to reference Efe C, Ozaslan E, Purnak T (2011) Outcome of pregnancy in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome: a report of two cases. Clin Res Hepatol Gastroenterol 35:687–689PubMed Efe C, Ozaslan E, Purnak T (2011) Outcome of pregnancy in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome: a report of two cases. Clin Res Hepatol Gastroenterol 35:687–689PubMed
109.
go back to reference Matsubara S, Isoda N, Taniguchi N (2011) Jaundice as the first manifestation of primary biliary cirrhosis during pregnancy: measurement of portal vein blood flow. The J of Obstet and Gynaecol Res 37:963–964 Matsubara S, Isoda N, Taniguchi N (2011) Jaundice as the first manifestation of primary biliary cirrhosis during pregnancy: measurement of portal vein blood flow. The J of Obstet and Gynaecol Res 37:963–964
110.
go back to reference Mitra S, Nayak PK, Padma A, Kurian G (2012) Successful pregnancy in autoimmune hepatitis/primary biliary cirrhosis overlap syndrome: a case report. Gastroenterol Res 5:208–210 Mitra S, Nayak PK, Padma A, Kurian G (2012) Successful pregnancy in autoimmune hepatitis/primary biliary cirrhosis overlap syndrome: a case report. Gastroenterol Res 5:208–210
111.
go back to reference Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156–J169PubMed Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156–J169PubMed
112.
go back to reference Riely CA (1999) Liver disease in the pregnant patient. Am J Gastroenterol 94:1728–1732PubMed Riely CA (1999) Liver disease in the pregnant patient. Am J Gastroenterol 94:1728–1732PubMed
113.
go back to reference Reyes H (1997) Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 12:211–216PubMed Reyes H (1997) Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 12:211–216PubMed
114.
go back to reference Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomaki K (2006) Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43:723–728PubMed Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomaki K (2006) Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43:723–728PubMed
115.
go back to reference Marinaccio M, Pinto V, Sambati GS, Papandrea D, De Veteris M (1992) Uncomplicated pregnancy in patients with unrecognized primary biliary cirrhosis. Minerva Ginecol 44:273–276PubMed Marinaccio M, Pinto V, Sambati GS, Papandrea D, De Veteris M (1992) Uncomplicated pregnancy in patients with unrecognized primary biliary cirrhosis. Minerva Ginecol 44:273–276PubMed
116.
go back to reference Bacq Y, Zarka O, Brechot JF, Mariotte N, Vol S, Tichet J et al (1996) Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 23:1030–1034PubMed Bacq Y, Zarka O, Brechot JF, Mariotte N, Vol S, Tichet J et al (1996) Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 23:1030–1034PubMed
117.
go back to reference Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, American Association for Study of Liver Diseases (2009) Primary biliary cirrhosis. Hepatology 50: 50:291-308 Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, American Association for Study of Liver Diseases (2009) Primary biliary cirrhosis. Hepatology 50: 50:291-308
118.
go back to reference Kam W, Clauser E, Kim YS, Kan YW, Rutter WJ (1985) Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc Natl Acad Sci U S A 82:8715–8719PubMedPubMedCentral Kam W, Clauser E, Kim YS, Kan YW, Rutter WJ (1985) Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc Natl Acad Sci U S A 82:8715–8719PubMedPubMedCentral
119.
go back to reference Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ et al (2003) Pediatric-onset primary biliary cirrhosis. Gastroenterology 125:1476–1479PubMed Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ et al (2003) Pediatric-onset primary biliary cirrhosis. Gastroenterology 125:1476–1479PubMed
120.
go back to reference Baker ER (1985) Body weight and the initiation of puberty. Clin Obstet Gynecol 28:573–579PubMed Baker ER (1985) Body weight and the initiation of puberty. Clin Obstet Gynecol 28:573–579PubMed
121.
go back to reference Floreani A, Ostuni PA, Ferrara F, Guido M (2006) Primary biliary cirrhosis: when and why does the disease develop? Dig Liver Dis 38:272–275PubMed Floreani A, Ostuni PA, Ferrara F, Guido M (2006) Primary biliary cirrhosis: when and why does the disease develop? Dig Liver Dis 38:272–275PubMed
122.
go back to reference Shah R (2007) Pregnancy in a woman with primary biliary cirrhosis: does it affect foetal outcome and progression of maternal disease? gastroenteroltoday 17:94–96 Shah R (2007) Pregnancy in a woman with primary biliary cirrhosis: does it affect foetal outcome and progression of maternal disease? gastroenteroltoday 17:94–96
123.
go back to reference Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP (1997) PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61:822–829PubMedPubMedCentral Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP (1997) PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61:822–829PubMedPubMedCentral
124.
go back to reference Nelson JL (1996) Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 39:191–194PubMed Nelson JL (1996) Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 39:191–194PubMed
125.
go back to reference Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A et al (1998) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351:559–562PubMed Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A et al (1998) Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351:559–562PubMed
126.
go back to reference Kobayashi H, Tamatani T, Tamura T, Kusafuka J, Yamataka A, Lane GJ et al (2007) Maternal microchimerism in biliary atresia. J Pediatr Surg 42:987–991PubMed Kobayashi H, Tamatani T, Tamura T, Kusafuka J, Yamataka A, Lane GJ et al (2007) Maternal microchimerism in biliary atresia. J Pediatr Surg 42:987–991PubMed
127.
go back to reference Czaja AJ (1994) Chronic graft-versus-host disease and primary biliary cirrhosis: sorting the puzzle pieces. Lab Invest 70:589–592PubMed Czaja AJ (1994) Chronic graft-versus-host disease and primary biliary cirrhosis: sorting the puzzle pieces. Lab Invest 70:589–592PubMed
128.
go back to reference Epstein O, Thomas HC, Sherlock S (1980) Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet 1:1166–1168PubMed Epstein O, Thomas HC, Sherlock S (1980) Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet 1:1166–1168PubMed
129.
go back to reference McDonnell WM (1998) Is primary biliary cirrhosis a complication of pregnancy? Hepatol: off j of the Am Assoc for the Study of Liver Dis 28:593–594 McDonnell WM (1998) Is primary biliary cirrhosis a complication of pregnancy? Hepatol: off j of the Am Assoc for the Study of Liver Dis 28:593–594
130.
go back to reference Invernizzi P, De Andreis C, Sirchia SM, Battezzati PM, Zuin M, Rossella F et al (2000) Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 122:418–422PubMedPubMedCentral Invernizzi P, De Andreis C, Sirchia SM, Battezzati PM, Zuin M, Rossella F et al (2000) Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 122:418–422PubMedPubMedCentral
131.
go back to reference Tanaka A (1999) Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 30:833–838PubMed Tanaka A (1999) Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 30:833–838PubMed
132.
go back to reference Corpechot C, Barbu V, Chazouilleres O, Poupon R (2000) Fetal microchimerism in primary biliary cirrhosis. J Hepatol 33:696–700PubMed Corpechot C, Barbu V, Chazouilleres O, Poupon R (2000) Fetal microchimerism in primary biliary cirrhosis. J Hepatol 33:696–700PubMed
133.
go back to reference Fanning PA, Jonsson JR, Clouston AD, Edwards-Smith C, Balderson GA, Macdonald GA et al (2000) Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol 33:690–695PubMed Fanning PA, Jonsson JR, Clouston AD, Edwards-Smith C, Balderson GA, Macdonald GA et al (2000) Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol 33:690–695PubMed
134.
go back to reference Stevens AM, McDonnell WM, Mullarkey ME, Pang JM, Leisenring W, Nelson JL (2004) Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest 84:1603–1609PubMed Stevens AM, McDonnell WM, Mullarkey ME, Pang JM, Leisenring W, Nelson JL (2004) Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest 84:1603–1609PubMed
135.
go back to reference Palmer JM, Kirby JA, Jones DE (2002) The immunology of primary biliary cirrhosis: the end of the beginning? Clin Exp Immunol 129:191–197PubMedPubMedCentral Palmer JM, Kirby JA, Jones DE (2002) The immunology of primary biliary cirrhosis: the end of the beginning? Clin Exp Immunol 129:191–197PubMedPubMedCentral
136.
go back to reference Bianchi I, Lleo A, Gershwin ME, Invernizzi P (2012) The X chromosome and immune associated genes. J Autoimmun 38:J187–J192PubMed Bianchi I, Lleo A, Gershwin ME, Invernizzi P (2012) The X chromosome and immune associated genes. J Autoimmun 38:J187–J192PubMed
137.
go back to reference Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1–5PubMed Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1–5PubMed
138.
go back to reference Thellin O, Coumans B, Zorzi W, Igout A, Heinen E (2000) Tolerance to the foeto-placental ‘graft’: ten ways to support a child for nine months. Curr Opin Immunol 12:731–737PubMed Thellin O, Coumans B, Zorzi W, Igout A, Heinen E (2000) Tolerance to the foeto-placental ‘graft’: ten ways to support a child for nine months. Curr Opin Immunol 12:731–737PubMed
139.
go back to reference Moreau P, Lefebvre S, Gourand L, Dausset J, Carosella ED, Paul P (1998) Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver. Hum Immunol 59:751–757PubMed Moreau P, Lefebvre S, Gourand L, Dausset J, Carosella ED, Paul P (1998) Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver. Hum Immunol 59:751–757PubMed
140.
go back to reference Thellin O, Heinen E (2003) Pregnancy and the immune system: between tolerance and rejection. Toxicology 185:179–184PubMed Thellin O, Heinen E (2003) Pregnancy and the immune system: between tolerance and rejection. Toxicology 185:179–184PubMed
141.
go back to reference Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ (2000) In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 85:1648–1657PubMed Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ (2000) In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 85:1648–1657PubMed
142.
go back to reference Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y et al (1997) Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 37:368–377PubMed Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y et al (1997) Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 37:368–377PubMed
143.
go back to reference Kuhnert M, Strohmeier R, Stegmuller M, Halberstadt E (1998) Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 76:147–151PubMed Kuhnert M, Strohmeier R, Stegmuller M, Halberstadt E (1998) Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 76:147–151PubMed
144.
go back to reference Veenstra van Nieuwenhoven AL V, Bouman A, Moes H, Heineman MJ, de Leij LF, Santema J et al (2002) Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril 77:1032–1037 Veenstra van Nieuwenhoven AL V, Bouman A, Moes H, Heineman MJ, de Leij LF, Santema J et al (2002) Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril 77:1032–1037
145.
go back to reference Kanik KS, Wilder RL (2000) Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy. Rheum Dis Clin North Am 26:805–823PubMed Kanik KS, Wilder RL (2000) Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy. Rheum Dis Clin North Am 26:805–823PubMed
146.
go back to reference Munoz-Valle JF, Vazquez-Del Mercado M, Garcia-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martinez-Bonilla G et al (2003) T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol 131:377–384PubMedPubMedCentral Munoz-Valle JF, Vazquez-Del Mercado M, Garcia-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martinez-Bonilla G et al (2003) T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol 131:377–384PubMedPubMedCentral
147.
go back to reference Groer MW, El-Badri N, Djeu J, Williams SN, Kane B, Szekeres K (2013) Suppression of natural killer cell cytotoxicity in postpartum women: time course and potential mechanisms. Biol Res for Nur 16:320–326 Groer MW, El-Badri N, Djeu J, Williams SN, Kane B, Szekeres K (2013) Suppression of natural killer cell cytotoxicity in postpartum women: time course and potential mechanisms. Biol Res for Nur 16:320–326
148.
go back to reference Chuang YH, Lian ZX, Tsuneyama K, Chiang BL, Ansari AA, Coppel RL et al (2006) Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 26:232–240PubMed Chuang YH, Lian ZX, Tsuneyama K, Chiang BL, Ansari AA, Coppel RL et al (2006) Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 26:232–240PubMed
149.
go back to reference Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L (2008) CD1d-restricted iNKT cells, the ‘Swiss-army knife’ of the immune system. Curr Opin Immunol 20:358–368PubMedPubMedCentral Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L (2008) CD1d-restricted iNKT cells, the ‘Swiss-army knife’ of the immune system. Curr Opin Immunol 20:358–368PubMedPubMedCentral
150.
go back to reference Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y et al (1997) In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 25:791–796PubMed Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y et al (1997) In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 25:791–796PubMed
151.
go back to reference Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS et al (2002) Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123:1031–1043PubMed Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS et al (2002) Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123:1031–1043PubMed
152.
go back to reference Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y (1998) Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 28:620–623PubMed Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y (1998) Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 28:620–623PubMed
153.
go back to reference Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y, Ridgway WM et al (2008) Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 47:571–580PubMed Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y, Ridgway WM et al (2008) Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 47:571–580PubMed
154.
go back to reference Aso-Ishimoto Y, Yamagiwa S, Ichida T, Miyakawa R, Tomiyama C, Sato Y et al (2014) Increased activated natural killer T cells in the liver of patients with advanced stage primary biliary cirrhosis. Biomed Res 35:161–169PubMed Aso-Ishimoto Y, Yamagiwa S, Ichida T, Miyakawa R, Tomiyama C, Sato Y et al (2014) Increased activated natural killer T cells in the liver of patients with advanced stage primary biliary cirrhosis. Biomed Res 35:161–169PubMed
155.
go back to reference Nakaya M, Tachibana H, Yamada K (2006) Effect of estrogens on the interferon-gamma producing cell population of mouse splenocytes. Biosci Biotechnol Biochem 70:47–53PubMed Nakaya M, Tachibana H, Yamada K (2006) Effect of estrogens on the interferon-gamma producing cell population of mouse splenocytes. Biosci Biotechnol Biochem 70:47–53PubMed
156.
go back to reference Southcombe J, Redman C, Sargent I (2010) Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women. J Reprod Immunol 87:52–59PubMedPubMedCentral Southcombe J, Redman C, Sargent I (2010) Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women. J Reprod Immunol 87:52–59PubMedPubMedCentral
157.
go back to reference Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423PubMed Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423PubMed
158.
go back to reference Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, DeLoia JA (2002) Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 72:874–884PubMed Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, DeLoia JA (2002) Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 72:874–884PubMed
159.
go back to reference Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA et al (2005) Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42:802–808PubMed Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA et al (2005) Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42:802–808PubMed
160.
go back to reference Gentile T, Llambias P, Dokmetjian J, Margni RA (1998) Effect of pregnancy and placental factors on the quality of humoral immune response. Immunol Lett 62:151–157PubMed Gentile T, Llambias P, Dokmetjian J, Margni RA (1998) Effect of pregnancy and placental factors on the quality of humoral immune response. Immunol Lett 62:151–157PubMed
161.
go back to reference Miller EC, Abel W (1984) Changes in the immunoglobulins IgG, IgA and IgM in pregnancy and the puerperium. Zentralbl Gynakol 106:1084–1091PubMed Miller EC, Abel W (1984) Changes in the immunoglobulins IgG, IgA and IgM in pregnancy and the puerperium. Zentralbl Gynakol 106:1084–1091PubMed
162.
go back to reference Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L et al (2012) Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 55:153–160PubMedPubMedCentral Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L et al (2012) Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 55:153–160PubMedPubMedCentral
163.
go back to reference Scaglione BJ, Salerno E, Gala K, Pan M, Langer JA, Mostowski HS et al (2009) Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice. J Autoimmun 32:14–23PubMed Scaglione BJ, Salerno E, Gala K, Pan M, Langer JA, Mostowski HS et al (2009) Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice. J Autoimmun 32:14–23PubMed
164.
go back to reference Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S (2004) Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10:347–353PubMed Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S (2004) Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10:347–353PubMed
165.
go back to reference Heikkinen J, Mottonen M, Alanen A, Lassila O (2004) Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 136:373–378PubMedPubMedCentral Heikkinen J, Mottonen M, Alanen A, Lassila O (2004) Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 136:373–378PubMedPubMedCentral
166.
go back to reference Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112:38–43PubMedPubMedCentral Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112:38–43PubMedPubMedCentral
167.
go back to reference Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM et al. (2006) Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(−) T-cells in decidua and maternal blood during human pregnancy. Placenta 27 Suppl A:S47–53 Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM et al. (2006) Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(−) T-cells in decidua and maternal blood during human pregnancy. Placenta 27 Suppl A:S47–53
168.
go back to reference Mjosberg J, Berg G, Ernerudh J, Ekerfelt C (2007) CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs. Immunology 120:456–466PubMedPubMedCentral Mjosberg J, Berg G, Ernerudh J, Ekerfelt C (2007) CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs. Immunology 120:456–466PubMedPubMedCentral
169.
go back to reference Jordan MA, Baxter AG (2008) The genetics of immunoregulatory T cells. J Autoimmun 31:237–244PubMed Jordan MA, Baxter AG (2008) The genetics of immunoregulatory T cells. J Autoimmun 31:237–244PubMed
170.
go back to reference Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M (2008) Pregnancy induces numerical and functional changes of CD4 + CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis 67:984–990PubMed Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M (2008) Pregnancy induces numerical and functional changes of CD4 + CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis 67:984–990PubMed
171.
go back to reference Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14:353–356PubMed Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14:353–356PubMed
172.
go back to reference Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC (2003) A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 9:163–174PubMed Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC (2003) A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 9:163–174PubMed
173.
go back to reference Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J (2004) TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 134:93–119PubMed Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J (2004) TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 134:93–119PubMed
174.
go back to reference Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG (1993) Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 151:4562–4573PubMed Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG (1993) Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 151:4562–4573PubMed
175.
go back to reference Choi BC, Polgar K, Xiao L, Hill JA (2000) Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 15(Suppl 1):46–59PubMed Choi BC, Polgar K, Xiao L, Hill JA (2000) Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 15(Suppl 1):46–59PubMed
176.
go back to reference Bernton EW, Meltzer MS, Holaday JW (1988) Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239:401–404PubMed Bernton EW, Meltzer MS, Holaday JW (1988) Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239:401–404PubMed
177.
go back to reference Andrews ZB (2005) Neuroendocrine regulation of prolactin secretion during late pregnancy: easing the transition into lactation. J Neuroendocrinol 17:466–473PubMed Andrews ZB (2005) Neuroendocrine regulation of prolactin secretion during late pregnancy: easing the transition into lactation. J Neuroendocrinol 17:466–473PubMed
178.
go back to reference Matalka KZ (2003) Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner. Cytokine 21:187–194PubMed Matalka KZ (2003) Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner. Cytokine 21:187–194PubMed
179.
go back to reference Matera L, Mori M (2000) Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. Ann N Y Acad Sci 917:505–513PubMed Matera L, Mori M (2000) Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells. Ann N Y Acad Sci 917:505–513PubMed
180.
go back to reference Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL et al (1995) Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 181:723–733PubMed Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL et al (1995) Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 181:723–733PubMed
181.
go back to reference Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H et al (1991) Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 146:89–94PubMed Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H et al (1991) Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 146:89–94PubMed
182.
go back to reference Lohr H, Fleischer B, Gerken G, Yeaman SJ, Buschenfelde KH M z, Manns M (1993) Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol 18:322–327PubMed Lohr H, Fleischer B, Gerken G, Yeaman SJ, Buschenfelde KH M z, Manns M (1993) Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol 18:322–327PubMed
183.
go back to reference Jones DE, Palmer JM, James OF, Yeaman SJ, Bassendine MF, Diamond AG (1995) T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 21:995–1002PubMed Jones DE, Palmer JM, James OF, Yeaman SJ, Bassendine MF, Diamond AG (1995) T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 21:995–1002PubMed
184.
go back to reference Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T et al (1986) Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 6:385–391PubMed Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T et al (1986) Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 6:385–391PubMed
185.
go back to reference Kita H (2007) Autoreactive CD8-specific T-cell response in primary biliary cirrhosis. Hepatol Res 37(Suppl 3):S402–S405PubMed Kita H (2007) Autoreactive CD8-specific T-cell response in primary biliary cirrhosis. Hepatol Res 37(Suppl 3):S402–S405PubMed
186.
go back to reference Nagano T, Yamamoto K, Matsumoto S, Okamoto R, Tagashira M, Ibuki N et al (1999) Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 19:422–427PubMed Nagano T, Yamamoto K, Matsumoto S, Okamoto R, Tagashira M, Ibuki N et al (1999) Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 19:422–427PubMed
187.
go back to reference Itoh S, Matsuzaki Y, Kimura T, Ikegami T, Shoda J, Fujiwara M et al (2000) Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction. J Gastroenterol Hepatol 15:443–451PubMed Itoh S, Matsuzaki Y, Kimura T, Ikegami T, Shoda J, Fujiwara M et al (2000) Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction. J Gastroenterol Hepatol 15:443–451PubMed
188.
go back to reference Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139–145PubMed Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139–145PubMed
189.
go back to reference Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132PubMed Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132PubMed
190.
go back to reference Acosta-Rodriguez Ev NGLASF (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942–949PubMed Acosta-Rodriguez Ev NGLASF (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942–949PubMed
191.
go back to reference Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas De St Groth B et al (2009) Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 183:7023–7030PubMed Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas De St Groth B et al (2009) Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 183:7023–7030PubMed
192.
go back to reference Saito S, Nakashima A, Shima T, Ito M (2010) Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63:601–610PubMed Saito S, Nakashima A, Shima T, Ito M (2010) Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 63:601–610PubMed
193.
go back to reference Rong G, Zhou Y, Xiong Y, Zhou L, Geng H, Jiang T et al (2009) Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 156:217–225PubMedPubMedCentral Rong G, Zhou Y, Xiong Y, Zhou L, Geng H, Jiang T et al (2009) Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol 156:217–225PubMedPubMedCentral
194.
go back to reference Tanaka H, Yang GX, Iwakoshi N, Knechtle SJ, Kawata K, Tsuneyama K et al (2013) Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 174:364–371PubMedPubMedCentral Tanaka H, Yang GX, Iwakoshi N, Knechtle SJ, Kawata K, Tsuneyama K et al (2013) Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 174:364–371PubMedPubMedCentral
195.
go back to reference Kawata K, Yang GX, Ando Y, Tanaka H, Zhang W, Kobayashi Y et al (2013) Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 58:1094–1104PubMedPubMedCentral Kawata K, Yang GX, Ando Y, Tanaka H, Zhang W, Kobayashi Y et al (2013) Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 58:1094–1104PubMedPubMedCentral
196.
go back to reference Dhirapong A, Yang GX, Nadler S, Zhang W, Tsuneyama K, Leung P et al (2013) Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 57:708–715PubMedPubMedCentral Dhirapong A, Yang GX, Nadler S, Zhang W, Tsuneyama K, Leung P et al (2013) Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 57:708–715PubMedPubMedCentral
197.
go back to reference Tsuda M, Zhang W, Yang GX, Tsuneyama K, Ando Y, Kawata K et al (2013) Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFbeta receptor type II mice. Hepatology 57:806–816PubMedPubMedCentral Tsuda M, Zhang W, Yang GX, Tsuneyama K, Ando Y, Kawata K et al (2013) Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFbeta receptor type II mice. Hepatology 57:806–816PubMedPubMedCentral
198.
go back to reference Ando Y, Yang GX, Tsuda M, Kawata K, Zhang W, Nakajima T et al (2012) The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology 56:1418–1426PubMedPubMedCentral Ando Y, Yang GX, Tsuda M, Kawata K, Zhang W, Nakajima T et al (2012) The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology 56:1418–1426PubMedPubMedCentral
199.
go back to reference Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP et al (2014) IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 59:1944–1953PubMed Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP et al (2014) IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 59:1944–1953PubMed
200.
go back to reference Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL et al. (2014) Ongoing activation of autoantigen-specific b cells in primary biliary cirrhosis. Hepatology Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL et al. (2014) Ongoing activation of autoantigen-specific b cells in primary biliary cirrhosis. Hepatology
201.
go back to reference Lleo A, Zhang W, McDonald WH, Seeley EH, Leung PS, Coppel RL et al. (2014) Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology Lleo A, Zhang W, McDonald WH, Seeley EH, Leung PS, Coppel RL et al. (2014) Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology
Metadata
Title
Women and Primary Biliary Cirrhosis
Authors
Ying Sun
Krista Haapanen
Baosen Li
Weici Zhang
Judy Van de Water
M. Eric Gershwin
Publication date
01-06-2015
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 2-3/2015
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-014-8449-4

Other articles of this Issue 2-3/2015

Clinical Reviews in Allergy & Immunology 2-3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.